Abstract
Pyrazolo[1,5-a]pyrimidines have been reported as potent inhibitors of mycobacterial ATP synthase for the treatment of Mycobacterium tuberculosis (M.tb). In this work, we report the design and synthesis of approximately 70 novel 3,5-diphenyl-N-(pyridin-2-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amines and their comprehensive structure–activity relationship studies. The most effective pyrazolo[1,5-a]pyrimidin-7-amine analogues contained a 3-(4-fluoro)phenyl group, together with a variety of 5-alkyl, 5-aryl and 5-heteroaryl substituents. A range of substituted 7-(2-pyridylmethylamine) derivatives were also active. Some of these compounds exhibited potent in vitro M.tb growth inhibition, low hERG liability and good mouse/human liver microsomal stabilities, highlighting their potential as inhibitors of M.tb.
Funder
Bill & Melinda Gates Foundation
U.S Agency for International Development
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference25 articles.
1. The history of tuberculosis
2. The History of Tuberculosis: From the First Historical Records to the Isolation of Koch’s Bacillus;Barberis;J. Prev. Med. Hyg.,2017
3. Epidemiology: A mortal foe
4. Global Tuberculosis Report 2021;World Health Organization,2021
5. Multidrug and extensively drug-resistant tuberculosis
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献